0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV82.76%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.63Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Bicara Therapeutics Stock Discussion
Breakthrough Cancer Drug Data: Bicara's Dual-Acting Treatment Takes On Aggressive Head & Neck Cancer
No comment yet